DUBE ERIC M (Chief Executive Officer) sold 12.9% of their position (64K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.63M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/16/2026ACC: 0001763494-26-000005
DirectorOfficer· Chief Executive Officer
Since Jan 2019
0.00
Net shares
Net seller
$2.63M
Total sold
3
Open market trades
0B · 3S
4
Total transactions
64K acquired · 64K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+64K
Price / share
—
Trade value
—
% of position
14.8%
4/13/2026
432.89K→496.89K
Common Stock
Direct
Shares
−56.81K
Price / share
$41.01
Trade value
$2.33M
% of position
11.4%
4/15/2026
496.89K→440.07K
Common Stock
Direct
Shares
−7.17K
Price / share
$41.75
Trade value
$299.14K
% of position
1.6%
4/15/2026
440.07K→432.91K
Common Stock
Direct
Shares
−20.00
Price / share
$42.66
Trade value
$853.20
% of position
0.0%
4/15/2026
432.91K→432.89K
Total
Net shares
+0.00
Net value
-$2.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/13/2026 | A · Award | +64K | — | — | 14.8% | 432.89K | 496.89K |
| Common Stock Direct | 4/15/2026 | S · Sale | −56.81K | $41.01 | $2.33M | 11.4% | 496.89K | 440.07K |
| Common Stock Direct | 4/15/2026 | S · Sale | −7.17K | $41.75 | $299.14K | 1.6% | 440.07K | 432.91K |
| Common Stock Direct | 4/15/2026 | S · Sale | −20.00 | $42.66 | $853.20 | 0.0% | 432.91K | 432.89K |
| Total | +0.00 | -$2.63M | ||||||
Derivative Transactions0
No derivative transactions reported